ada standards of care 2025 obesity pharmacotherapy glp-1 ACC Scientific Statement on the Management in Adults With Heart Failure: A Report of the American College of Cardiology When to use pharmacotherapy for

Zepbound Lawsuit 2026 Update July 1, 2026: Over 80 Lawsuits About Zepbound, Similar GLP-1 Drugs Join the MDL The consolidated multidistrict litigation about Zepbound and other GLP-1 products has grown to include 3,848 lawsuits as of July 1, 2026

First try reducing sodium intake, increasing potassium-rich foods, and ensuring adequate hydration

PMID 31243305

Dasiglucagon effectively mitigates postbariatric postprandial hypoglycemia: a randomized, double-blind, placebo-controlled, crossover trial

Because K+ channels are required for membrane repolarization in TASR, these cells remain in a depolarized state for an extended period, resulting in prolonged bitter signaling (74)

Sure, our salary will influence many aspects of our lives, but it cant determine our happiness, sense of purpose, or whether were living in alignment with our values